Dr. Jeffrey Stern

Dr. Jeffrey Stern
Jeffrey A. Stern, MD, FACS Dr. Jeffrey A. Stern is an international speaker and a leader in the field of urologic surgery. He has presented at conferences throughout the United States and in Europe. Recently, he was invited to Kyoto University in Japan as a visiting professor to lecture about the da Vinci robotic prostatectomy. The robotic prostatectomy is the most advanced treatment for prostate cancer. During his laparoscopic fellowship at the Mayo Clinic in Scottsdale, Arizona, Dr. Stern was involved in hundreds of laparoscopic procedures. His expertise is in minimally invasive surgery for prostate cancer, kidney cancer, and bladder prolapse. Dr. Stern attended prep-school at the prestigious Phillips Academy in Andover, Massachusetts. Following Andover, he attended college and medical school at Northwestern University in Chicago, Illinois. He completed his urology residency at Northwestern Memorial Hospital, where he worked with leaders in the nerve-sparing technique of radical prostatectomy. While at the Mayo Clinic in Scottsdale, Arizona, Dr. Stern applied his expertise in the potency-preserving technique to robotic surgery. Dr. Stern continues his interest in cutting-edge technology, and is also proficient in robotic surgery and minimally-invasive surgery for bladder prolapse and urinary incontinence, interstim treatment for urinary urgency and incontinence, and benign prostatic hyperplasia (BPH).
Medical School:

Northwestern University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only